These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6579963)

  • 1. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
    Maxwell RE; Nawrocki JW; Uhlendorf PD
    Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats.
    Krause BR; Newton RS
    Atherosclerosis; 1986 Jan; 59(1):95-8. PubMed ID: 3081014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
    Hall MJ; Nelson LM; Russell RI; Howard AN
    Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Fears R; Richards DH; Ferres H
    Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
    Krause BR; Newton RS
    J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
    Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
    Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
    Kähönen MT; Ylikahri RH
    Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.
    Shand JH; West DW
    Lipids; 1994 Nov; 29(11):747-52. PubMed ID: 7869854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L; Szostak WB
    Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of adipocyte cholesterol during hypolipidemic drug treatment in cholesterol-fed rats.
    Krause BR; Hartman AD
    Biochim Biophys Acta; 1982 Dec; 713(3):485-93. PubMed ID: 7150624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
    Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
    J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
    Ståhlberg D; Angelin B; Einarsson K
    J Lipid Res; 1989 Jul; 30(7):953-8. PubMed ID: 2794793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD; Dietschy JM
    J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects.
    Leiss O; von Bergmann K; Gnasso A; Augustin J
    Metabolism; 1985 Jan; 34(1):74-82. PubMed ID: 3855325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferators gemfibrozil and clofibrate on syntheses of dolichol and cholesterol in rat liver.
    Shiota Y; Ikeda M; Hashimoto F; Hayashi H
    J Biochem; 2003 Aug; 134(2):197-202. PubMed ID: 12966067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gemfibrozil on high-density lipoproteins.
    Glueck C
    Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.